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Penyakit Alzheimer berkait dengan peningkatan kematian sel neuron dan gangguan 
fungsi kognitif. Penyakit ini dicirikan oleh pembentukan plak di otak. Pengumpulan 
peptida beta amiloid (Aβ) dipercayai merupakan penanda awal kepada patofisiologi 
penyakit Alzheimer. Walau bagaimanapun, mekanisma toksisiti Aβ masih tidak diketa-
hui tetapi mungkin melibatkan peningkatan tekanan oksidatif. Oleh itu, kajian ini dija-
lankan untuk menentukan kesan toksik Aβ terhadap DNA - biomolekul penting yang 
dioksidakan oleh radikal bebas, dan apoptosis sel serta modulasinya oleh fraksi kaya 
tokotrienol (TRF), sejenis antioksidan. Sel titian neuroblastoma diperlakukan sama ada 
dengan 10μM peptida Aß, 5μg/ml TRF diikuti dengan 10μM peptida Aß atau 10μM 
peptida Aß peptide diikuti dengan  5μg/ml TRF. Sel yang tidak dperlakukan dengan Aß 
atau TRF dijadikan sebagai kawalan. Kerosakan DNA ditentukan dengan mengguna-
kan asai komet, viabiliti sel ditentukan menggunakan asai 3-(4,5-dimetiltiazol-2-il)-5-(3-
karboksimetoksifenil)2-(4-sulfofenil)-2H-tetrazolium (MTS) dan pewarnaan propidium 
iodida dan calcein-AM dijalankan untuk menentukan bilangan sel yang hidup dan sel 
yang mengalami apoptosis. Keputusan menunjukkan bahawa peptida Aß mening-
katkan kerosakan DNA secara signifikan berbanding kawalan (p<0.05) dan mening-
katkan kematian sel. Walau bagaimanapun, perlakuan dengan TRF mengurangkan 
kerosakan DNA secara signifikan, meningkatkan bilangan sel hidup dan mengurang-
kan jumlah sel yang mengalami apoptosis berbanding kumpulan yang diaruh oleh 
peptida Aß sahaja (p<0.05). Oleh itu, kajian ini menujukkan peptida Aß menyebabkan 
kerosakan DNA dan kematian sel melalui apoptosis kemungkinan disebabkan oleh 
aruhan kerosakan oksidatif pada DNA. Ini disokong oleh fakta di mana TRF, suatu an-
tioksidan, berupaya melindungi kerosakan DNA dan apoptosis. 
 






Alzheimer’s disease (AD) is associated with increase neuron cell death and decline in 
cognitive function. This disease is characterized by plaque formation in the brain. It is 
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believed that accumulation of beta amyloid peptide (Aβ) is an early sequence in the 
pathophysiology of AD. However, the mechanism of Aβ toxicity is unknown but may 
involve increase oxidative stress. This study was thus undertaken to determine the 
toxic effect of Aβ on DNA - an important biomolecule which is oxidized by free radicals, 
and cell apoptosis and its modulation by tocotrienol rich fraction (TRF). Neuroblastoma 
SH-SY5Y cell lines were treated either with 10μM Aß peptide; 5μg/ml TRF followed by 
10μM Aß peptide or 10μM Aß peptide followed by 5μg/ml TRF. Untreated cells served 
as control. DNA damage was evaluated by the alkaline comet assay, cell viability by 
the 3-(4,5-dimetiltiazol-2-il)-5-(3-karboksimetoksifenil)2-(4-sulfofenil)-2H-tetrazolium 
(MTS) and the propidium iodide & calcein-AM staining to determine the number of 
viable and apoptotic cells. Results showed that Aß peptide induced a significantly 
higher DNA damage compared to control (p<0.05) and higher number of cell death. 
However treatment with TRF resulted in significantly less DNA damage, higher cell 
survival and decreased number of apoptotic cells as compared to Aß peptide treated 
cells (p<0.05,). Thus this study showed that Aß peptide causes DNA damage and 
ultimately cell death via apoptosis probably by inducing oxidative DNA damage. This is 
further supported by the fact that TRF is able to prevent the DNA damage and 
apoptosis. 
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Alzheimers disease (AD) is characterized 
by regional neurodegeneration, synaptic 
loss and the presence of senile plaques 
(SantaCruz et al. 2005). The senile 
plaques consist of abnormal interneu-
ronal growth, dead cells and beta 
amyloid. There has been increasing evi-
dence which suggests that the buildup 
and aggregation of beta amyloid peptide 
(Aβ) in the brain plays a primary role in 
the pathogenesis of AD (Piccini et al. 
2005).  
 Although Aβ has been demonstrated to 
be neurotoxic in cell culture (Butterfield et 
al. 2004), the mechanism by which it ex-
erts its toxicity is still unclear. Several 
mechanisms have been suggested in-
cluding increased sensitivity to excito-
toxins, alterations to calcium homeosta-
sis (Celsi et al. 2006), activation of re-
ceptor that precipitates cell destruction 
and activation of inflammatory pathways 
(Zou et al. 2006).   
 Recently, the involvement of oxidative 
stress in the pathogenesis of AD has 
been suggested (Wang et al. 2008). The 
AD brain was reported to have increased 
lipid peroxidation, increased carbonyl 
modification of proteins and increased 
oxidation of mitochondrial DNA (Arimura 
& Kaibuchi 2005).  
 Increase oxidative stress occurs when 
the balance between free radical genera-
tion and antioxidant capacities shifts to-
ward free radical generation leading to 
oxidative damage to lipids, protein, RNA 
and DNA. This is not surprising as the 
brain is more susceptible to oxidative 
damage compared to other organs or 
tissues, due to its high rate of oxygen 
consumption, high polyunsaturated lipid 
content, and relative paucity of antioxi-
dant enzymes (Puttfarcken 1996).  
Understanding how Aβ acts and its 
probable association to oxidative stress 
is important for the formulation of treat-
ment and preventive steps against neu-
rodegeneration. Therefore, in this study, 
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the involvement of oxidative damage in 
the mechanism of Aβ-toxicity resulting in 
neuronal cell death was determined by 
measuring oxidative DNA damage. The 
involvement of oxidative damage was 
further elucidated by determining the ef-
fect of TRF. 
 
MATERIALS AND METHODS 
 
SH-SY5Y neuroblastoma cell culture 
 
Human neuroblastoma SH-SY5Y cells 
were gifts from Dr. Coral Sanfeliu of the 
Institut d’Investigacions Biomèdiques de 
Barcelona, Spain. Cells were grown un-
der the following condition: 50% of 
EMEM with Earles Salt pH 7.2 (Flowlab, 
Australia) and 50% Ham's F-12 pH 7.2 
(Sigma, USA) supplemented with 200mM 
Non-essential amino acid (NEAA) 
(Flowlab, Australia), 10mg/ml gentamicin 
(PAA, Austria) and 10% Foetal Bovine 
Serum (FBS), heat inactivated (PAA, 
Austria). Cells were subcultured after 
wash with phosphate buffered saline 
(PBS) and trypsin. Cells were then 
seeded at 1.5 x 104 cells per ml on 96-
well plates. Cultures were maintained in 
5% CO2 / 95% air at 37OC. Experiments 
were carried out on the 7th-9th day. 
 
Preparation of Aggregated Aβ 
 
The stock solution of Aβ1-42 (Calbiochem, 
German) was dissolved at 1mg/ml in 
50Mm Tris-HCL, pH ≥ 9.0. The peptide 
was diluted to 20μΜ with calcium, mag-
nesium-free PBS and stored at -20oC. 
The stock solution was then diluted to a 
final concentration of 10μΜ followed by 





Cells were divided into 4 groups: un-
treated cells served as control, treated 
with 10μM Aß peptide for 24 hours, 
5μg/ml TRF for 24 hours followed by 
10μM Aß peptide for 24 hours (pre 
treatment) or 10μM Aß peptide for 24 
hours followed by 5μg/ml TRF for 24 
hours (post treatment). All cultures were 
maintained in 5% CO2 / 95% air at 37oC. 
TRF was purchased from Golden Hope 
Biorganic Sdn. Bhd. (Malaysia). DNA 
damage, cell viability and apoptosis were 
determined by using MTS assay, comet 
assay and Propidium Iodide & Calcein-




DNA damage was determined by using 
the Comet assay according to the me-
thod described by Singh et al. (1988), 
with minor modifications. 105μl of normal 
melting agarose (NMA) was added to 
frosted microscope slides (Curtin 
Matherson, USA), covered with cover-
slips and kept for 10 minutes to solidify. 
Coverslips were removed and 20μl cells 
with 80μl low melting point agarose 
(LMA) were added to the slides (Sigma, 
USA). The slides were then immersed in 
a jar containing cold lysing solution (2.5 
M NaCl, 100 mM ethylene-diaminetetra-
acetic acid, 10 mM Tris at pH 10, 1% 
Triton X-100, 1% sodium N-lauroyl sar-
cocinate, 10% dimethylsulfoxide)  for at 
least 1 hour. After lysis, the slides were 
placed in electrophoresis box filled with 
electrophoresis buffer (0.3 M NaOH and 
1 mM ethylene-diaminetetra-acetic acid). 
The cells were incubated for 20 minutes 
to allow for unwinding of DNA and ex-
pression of alkali-labile sites. All of these 
steps were conducted under dim light to 
prevent additional DNA damage. After 
electrophoresis, neutralization buffer 
(0.4M Tris, pH 7.5) was added to neu-
tralize the alkali, and the slides were left 
at room temperature for 5 minutes. This 
step was repeated twice. Ethidium bro-
mide (Sigma, USA) was added to each 
slide, covered with a coverslip, kept in a 
humidified box and finally analyzed using 
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a fluorescence microscope (AxioCam 




The MTS assay purchased from 
(Promega, USA), employs MTS and the 
electron coupling agent phenazine me-
thosulphate (PMS). MTS is converted 
into a medium soluble formazan product 
by dehydrogenase enzymes found in 
metabolically active cells. 20 μl of MTS 
reagents was pipetted into each well 
containing the samples in 100μl of cul-
ture medium. The plates were then incu-
bated for 2 hours in 5% CO2/95% air at 
37oC. The optical density (OD) of the 
wells was determined using a microplate 
reader at 490-nm wavelength (Versa 
max, Japan). 
 
Propidium Iodide & Calcein-AM staining 
 
Staining to detect cell death is based on 
the principle that live cells have intracel-
lular esterase that converts non-fluores-
cent cell-permeable calcein-AM to the 
intensely fluorescent calcein which is re-
tained within the cells. Viable cell mem-
branes are impermeable to propidium 
iodide. Dead cells however, allow propi-
dium iodide to enter and bind to nucleic 
acid. Thus live cells stained green with 
calcein-AM while dead and apoptotic 
cells stained red with propidium iodide 
(Sigma, USA). 30μg/ml calcein-AM and 
7.5 μg/ml propidium iodide were added to 
the cell cultures in chamber slides (Nunc, 
Denmark) and incubated for 30 minutes. 
Thereafter, cultures were washed with 
PBS, fixed with fresh 4% paraformalde-
hyde and then incubated for 30 minutes 
at 37OC. Slides were washed and cover-
slips mounted for microscopic examina-





DNA Damage Studies 
 
Figure 1 shows DNA damage in the 
treated and untreated cells as deter-
mined by comet assay. Cells were 
grouped according to the length of comet 
tail (%). Cells without DNA fragmentation 
were classified as no DNA damage, cells 























Figure 1 : DNA damage in untreated (control) and cells treated with either 10µM Aβ peptide, Aβ then 5 
µg/ml TRF or TRF then Aβ peptide.  DNA was stained with ethidium bromide and was visible as comet tail 
under fluorescence microscope. Length of comet tail is associated with severity of DNA damage. Thus cell 
was classified as having no damage (I), mild damage (II) and severe damage (III). Results showed that 
neuron cells exposed to 10μM Aß peptide showed a significantly (p<0.05) higher percentage of DNA 
damage compared to control. Treatment with TRF significantly lowers the DNA damage induced by 10μM 
Aß. *Denotes p<0.05 compared to cells exposed to Aβ peptide only. Data is presented as means + SD. n=9. 
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as having mild damage and cells with 
major fragmentation as severely dam-
aged. Results showed that incubation 
with 10μM Aß peptide significantly in-
creased the DNA damage (p<0.05). 
However, cells treated with TRF before 
(pre treatment) or after (post treatment) 
incubation with Aβ was observed to have 
a significantly reduced number of DNA 
damage. There was no significant differ-
ence observed between the number and 
severity of DNA damage in pre and post 
TRF treated groups. 
 
Determination of Aβ Peptide toxicity  
 
The concentration of Aβ peptide which 
can induce 50% cell death (IC50) was 
determined by incubating cells with in-
creasing concentration of Aβ peptide. 
Figure 2 shows that this concentration 
was 10μM and hence 10μM Aβ peptide 
was the concentration used in subse-
quent experiments. 
 
Neuroprotection  Studies 
 
Figure 3 shows that 10μM Aβ signifi-
cantly increased neuronal death. Pre and 
post treatment with 5μg/ml TRF signifi-
cantly increased the number of viable 
cells compared to the cells treated with 
Aβ only and thus demonstrated that TRF 
was able to prevent cell death induced by 
Aß peptide. 
Figure 4 shows the results of fluores-
cence staining using calcein AM and 
propidium iodide. Control live neuron 
cells were stained green (a) whereas 
cells exposed to 10μM Aß peptide were 
stained red with (i) cell shrinkage and (ii) 
condensed chromatins, characteristics of 
apoptotic cells (b). Cells pretreated with 
5μg/ml TRF before exposure to Aß un-
derwent early apoptosis but still retained 
membrane integrity (c). TRF post treated 
cells showed increased number of viable 
cells compared to cells exposed to Aβ 
only demonstrating that post treatment of 
cells with TRF prevented cell death in-




Recent evidence suggests that Aβ pep-
tide may contribute to the progressive 
neuronal loss and/or may be directly neu-
rotoxic both in vitro and in vivo (Pike et 
al. 1993). This is consistent with the 
present finding where Aβ peptide was
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Figure 2 : Viability of neuron cells exposed to Aß peptide was determined using the MTS assay. Incubation 
with varying concentrations of Aß peptide for 24 hours significantly (p<0.05) decreased the number of viable 
neuron cells. Concentration of Aß peptide which reduced 50% of neuron cells (IC50) was found to be 10μM 
Aß. 
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Figure 3 : Neuroprotection of TRF against Aß peptide induced cell death using MTS assay.  Neuron cells 
pretreated and posttreated with 5μg/ml TRF for 24 hours showed a significant increase in percentage of 
viable cells compared to cells exposed to Aβ peptide. TRF was able to protect against cell death at a 































Figure  4: Neuroprotective effect of TRF against Aß peptide induced cell death using the Calcein AM and 
propidium iodide staining. Live cells were stained green, dead cells were stained red. Micrographs are 
labeled as a) control : live cells, b) exposed to 10μM Aß peptide : cells underwent apoptosis with the 
characteristic (i) cell shrinkage and (ii) condensed chromatins, c) 5μg/ml TRF followed by 10μM Aß peptide : 
underwent early apoptosis but still retained membrane integrity d) 10μM Aß peptide followed by 5μg/ml TRF 
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observed to significantly decrease the 
number of viable cells (Figure 2). The 
induction of cell death may be elicited via 
apoptosis (Behl et al. 1994). The present 
finding (Figure 4b) showed that the num-
ber of apoptotic cells was increased while 
the number of viable cells decreased 
when exposed to Aβ peptide.  
 Aβ peptide may exert its cytotoxic ef-
fects by activating the apoptotic pathway 
via free radical damage and/or induction 
of the signaling molecules (Pereira et al. 
1999). Free radicals are constantly gen-
erated in vivo and have been reported to 
be significant contributors to the devel-
opment of chronic degenerative disorders 
such as Alzheimers disease (Ames et al. 
1993). Although multiple antioxidant re-
pair systems exist to help control this 
process, reactive species still cause 
damage to biomolecules, cells and tis-
sues.  
 DNA damage is probably the most sig-
nificant biological target because this 
may ultimately lead to altered gene ex-
pression, disruption of cellular repair me-
chanism and distorted cellular function 
(Heaton et al. 2002). Thus DNA damage 
was measured in this study after cells 
were incubated with Aβ peptide with and 
without treatment with TRF. 
 Comet assay was used to measure 
DNA damage and visual scoring method 
was applied to evaluate the amount of 
DNA damage (Collins 2004). The present 
results showed that DNA damage was 
significantly increased in cells incubated 
with Aβ peptide (Figure 1). This may be 
attributed to the observation that Aβ pep-
tide could generate ROS which contri-
bute to the DNA damage.  
 Treatment with TRF, either before (pre) 
or after (post-treatment) incubation with 
Aβ peptide confirmed the neuroprotective 
effect of TRF. The data from this study 
showed that TRF prevented cell death, 
minimized apoptosis and reduced the 
DNA damage induced by Aβ peptide. 
Many studies have shown that vitamin E 
and its isomers exert neuroprotective 
effects against ROS-induced cell death in 
vitro (Sen et al. 2006; Mazlan et al. 
2006). A recent report also demonstrated 
that AD patients with moderately severe 
impairment respond favorably to α-toco-
pherol by slowing the progression of the 
disease (Sano et al. 1997). An epidemi-
ological study involving 633 persons over 
65 years old suggests that the use of 
high dose vitamin E supplements may 
lower the risk of AD (Morris et al. 1998). 
The neuroprotective effect of TRF may 
be exerted via its antioxidant effects or by 
acting at the gene level, affecting the ex-
pressions of the signaling molecules of 
the apoptotic pathway.  
 The results thus show the relationship 
between the oxidative DNA damage, 
apoptosis and cell death induced by Aβ 
peptide which is prevented by TRF. In 
conclusion, Aβ peptide cause DNA dam-
age and ultimately cell death via apopto-
sis probably by inducing oxidative DNA 
damage. This is further supported by the 
fact that TRF, an antioxidant is able to 
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